Research
Title : | A phase 2a double-blind, placebo-controlled randomized clinical trial to evaluate immunogenicity & safety of a Zika virus vaccine (Bbv121) in Dengue sero-negative & dengue sero-negative & Dengue sero-positive healthy adults |
Area of research : | Medical Sciences |
Focus area : | Task Force (TF) |
Principal Investigator : | Mr. M.V. Murhekar Director All India Institute of Medical Sciences Delhi |
Timeline Start Year : | 2020 |
Timeline End Year : | 2021 |
Details
Total Budget (INR): | 5,57,41,775 |
Organizations involved
Implementing Agency : | All India Institute of Medical Sciences Delhi |
Funding Agency : | Indian Council of Medical Research (ICMR) |